Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008...(Inc. Contacts: William R. LaRue ....)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Date:3/13/2008
Inc.
Contacts: William R. LaRue
SVP & Chief Financial Officer
Cadence Pharmaceuticals, Inc.
858-436-1400
Anna Gralinska
Director, Investor Relations
Cadence Pharmaceuticals, Inc.
(858) 436-1452
'/>"/>
| SOURCE Cadence Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
2. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
3. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. NPS Pharmaceuticals Reports 2007 Financial Results
Post Your Comments:
Breaking Biology Technology:La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
[0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Quest Diagnostics Declares Quarterly Cash Dividend[0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
Other Biology Technology:Designing Controls for siRNA , Experiments 2Designing Controls for siRNA , Experiments 3Designing Controls for siRNA , Experiments 4Designing Controls for siRNA , Experiments 5Detecting Attomole Amounts of Small RNA 2Detecting Attomole Amounts of Small RNA 3Five Ways to Produce siRNAs 2Five Ways to Produce siRNAs 3Five Ways to Produce siRNAs 4Five Ways to Produce siRNAs 5Five Ways to Produce siRNAs 6Five Ways to Produce siRNAs 7Five Ways to Produce siRNAs 8Five Ways to Produce siRNAs 9Five Ways to Produce siRNAs 10Five Ways to Produce siRNAs 11Five Ways to Produce siRNAs 12Five Ways to Produce siRNAs 13Five Ways to Produce siRNAs 14Five Ways to Produce siRNAs 15Five Ways to Produce siRNAs 16Five Ways to Produce siRNAs 17Five Ways to Produce siRNAs 18Five Ways to Produce siRNAs 19Five Ways to Produce siRNAs 20
Breaking Biology News(10 mins):ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Studying hair of ancient Peruvians answers questions about stress 2Elluminate 26apos 3Bs Fire and Ice Project Recognized as First Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 62141 1Elluminate 26apos 3Bs Fire and Ice Project Recognized as First Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 62141 2Elluminate 26apos 3Bs Fire and Ice Project Recognized as First Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 62141 3Elluminate 26apos 3Bs Fire and Ice Project Recognized as First Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 62141 4Elluminate 26apos 3Bs Fire and Ice Project Recognized as First Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 62141 5dazzlesmile Sues Epic Advertising and Jesse Willms 62136 1dazzlesmile Sues Epic Advertising and Jesse Willms 62136 2For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 1For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 2
Other Biology News:Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 2Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 3Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 4bioMETRX, Inc. Completes Sequiam Asset Purchase 2Insect warning colors aid cancer and tropical disease drug discovery 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |